Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by porksnifferon Aug 18, 2021 12:15pm
181 Views
Post# 33723703

RE:RE:RE:RE:RE:RE:RE:RE:RE:Analyst's Reports

RE:RE:RE:RE:RE:RE:RE:RE:RE:Analyst's Reports
EbbFlow88 wrote: There have been many new investors since march 2020 that have built positions recently. The stock has been trading between 5 and 5.60 for the last number of months. 

Personally I initiated a position in the mid 6's but have since gone in much bigger between 5.10 and 5.30. My ACB is now just under 5.40

There are a few new faces here that I'm sure have an even better cost basis than me.

2% gain isn't anything to brag about, but even those that are still in the red (I assume Mugsy considering how long he's been here) are still very bullish and comfortable with what we own.

A while back you said Goodman will buy it back privately under $4, now its $5.50. Even you are getting more bullish.



So you're in the green by 2%. You could have invested ANYWHERE else including oil and done MUCH better. There is opportunity costs too. The corpses of 'value' guys is piling up in here. 

Never said it will be taken privately under $4 as the stock has not traded there. You have me mistaken for someone else. If it continues like this it will be taken private; JRG does not like the negative media attention he has recieved. The bloom is off the rose and he knows it. Ten years doesn't mean do nothing for 9 years but drop 50%. This has been a failure of epic proportions so much so the shareholder base has been flipping. 

Mugs is a fraud, a liar and the lowest of the low. He has been banned, reborn, caught in lies, banned again reborn and back yet again. Called him out years ago to post his position and all his 'accumulation' but he was too much of a liar and a coward to post it. He was jumping with his pom poms in the $10 range all the way down. How many people has he destroyed in Antibe? He's a paid pumper, lowest of the low. 

<< Previous
Bullboard Posts
Next >>